Researchers conducted an observational study of 600 patients who used FDgard to manage their functional dyspepsia.
Ann Arbor-based Michigan Medicine Gastroenterology Clinic Director William Chey, MD, presented the results at ACG 2017.
Here’s what you should know:
1. Approximately 95 percent of patients experienced either major or moderate improvements of their functional dyspepsia.
2. Concerning epigastric pain syndrome, 92.5 percent of patients experienced improved upper abdominal pain.
3. Around 86.5 percent of postprandial distress syndrome patients achieved symptom relief within two hours of taking FDgard.
ACG 2017 took place in Orlando, Fla., Oct. 13 to Oct. 18.
More articles on gastroenterology:
GI center to know: Affiliated Endoscopy Services of Clifton
Atlantic Digestive Specialists, Gastro Health & more — 3 GI practices in the news
Motus GI’s Pure-Vu system effective in adequately prepping colons — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.